ImmunoGen
NASDAQ: IMGN
$31.23
+$0.00 (+0.0%)
Closing price February 26, 2024
24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the month of March.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Wednesday include AK Steel, Apple, Biogen, Electronic Arts, FitBit, Foot Locker, McDonald's and Pfizer.
Published:
Last Updated:
Cancer drug developer ImmunoGen posted sharply lower profits and revenues than analysts were expecting. The stock is taking a beating as a result.
Published:
Last Updated:
ImmunoGen saw its shares make a sharp turn downward on Thursday morning after the stock has seen an incredible year of trading so far.
Published:
Last Updated:
ImmunoGen announced this week that it has decided to partner with Jazz Pharmaceuticals, and investors have pushed Immunogen shares to a new 52-week high.
Published:
Last Updated:
ImmunoGen has decided to partner with Jazz Pharmaceuticals for the development and commercialization of two early-stage, hematology-related antibody-drug conjugate programs.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Thursday include AutoZone, O'Reilly Automotive, Immunogen, Medtronic, Nike, OncoSec Medical and Schlumberger.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Thursday include Amarin, American Express, Barrick Gold, Cameco, Groupon, ImmunoGen, JPMorgan and Whole Foods Market.
Published:
Last Updated:
ImmunoGen watched its stock make a handy gain after the firm announced that had amended its license agreements with Sanofi.
Published:
Last Updated:
October 14, 2016: Here are four stocks trading with relatively heavy volume among 57 equities making new 52-week lows in Friday’s session. On the NYSE, advancers led decliners by just better...
Published:
Last Updated:
July 15, 2016: Here are four stocks trading with relatively heavy volume among just 11 equities making new 52-week lows in Friday’s session. Volumes only rose above 1 million for two of the...
Published:
Last Updated:
July 14, 2016: Here are four stocks trading with relatively heavy volume among just 13 equities making new 52-week lows in Thursday’s session. Volumes did not rise about 1 million for any of...
Published:
Last Updated:
July 13, 2016: Here are four stocks trading with relatively heavy volume among 11 equities making new 52-week lows in Wednesday’s session. NYSE decliners led advancers by a small margin and...
Published:
Last Updated:
June 15, 2016: Here are four stocks trading with relatively heavy volume among 28 equities making new 52-week lows in Wednesday’s session. NYSE advancers led decliners by less than 2 to 1 while...
Published:
Last Updated:
June 14, 2016: Here are four stocks trading with relatively heavy volume among 97 equities making new 52-week lows in Tuesday’s session. NYSE decliners led advancers by about 2 to 1 while...
Published:
Last Updated: